1. Raisz LG. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest. 2005. 115:3318–3325.
Article
2. Manolagas SC, Jilka RL. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med. 1995. 332:305–311.
Article
3. Adams GB, Scadden DT. The hematopoietic stem cell in its place. Nat Immunol. 2006. 7:333–337.
Article
4. Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, Knight MC, et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature. 2003. 425:841–846.
Article
5. Taichman RS, Emerson SG. Human osteoblasts support hematopoiesis through the production of granulocyte colony-stimulating factor. J Exp Med. 1994. 179:1677–1682.
Article
6. Taichman RS, Reilly MJ, Emerson SG. Human osteoblasts support human hematopoietic progenitor cells in vitro bone marrow cultures. Blood. 1996. 87:518–524.
Article
7. Visnjic D, Kalajzic I, Gronowicz G, Aguila HL, Clark SH, Lichtler AC, et al. Conditional ablation of the osteoblast lineage in Col2.3deltatk transgenic mice. J Bone Miner Res. 2001. 16:2222–2231.
Article
8. Visnjic D, Kalajzic Z, Rowe DW, Katavic V, Lorenzo J, Aguila HL. Hematopoiesis is severely altered in mice with an induced osteoblast deficiency. Blood. 2004. 103:3258–3264.
Article
9. Wu JY, Scadden DT, Kronenberg HM. Role of the osteoblast lineage in the bone marrow hematopoietic niches. J Bone Miner Res. 2009. 24:759–764.
Article
10. WHO scientific group on the prevention and management of osteoporosis. WHO technical report series, 921. Prevention and management of osteoporosis: report of a WHO scientific group. 2000. Geneva: WHO Library.
11. Taaffe DR, Cauley JA, Danielson M, Nevitt MC, Lang TF, Bauer DC, et al. Race and sex effects on the association between muscle strength, soft tissue, and bone mineral density in healthy elders: the Health, Aging, and Body Composition Study. J Bone Miner Res. 2001. 16:1343–1352.
Article
12. Aguila HL, Rowe DW. Skeletal development, bone remodeling, and hematopoiesis. Immunol Rev. 2005. 208:7–18.
Article
13. Taichman RS. Blood and bone: two tissues whose fates are intertwined to create the hematopoietic stem-cell niche. Blood. 2005. 105:2631–2639.
Article
14. Hughes DE, Salter DM, Dedhar S, Simpson R. Integrin expression in human bone. J Bone Miner Res. 1993. 8:527–533.
Article
15. Zhang J, Niu C, Ye L, Huang H, He X, Tong WG, et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature. 2003. 425:836–841.
Article
16. Taichman RS, Emerson SG. The role of osteoblasts in the hematopoietic microenvironment. Stem Cells. 1998. 16:7–15.
Article
17. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell. 1997. 89:755–764.
Article
18. Chappard D, Legrand E, Audran M, Basle MF. [Histomorphometric measurement of the architecture of the trabecular bone in osteoporosis: comparative study of several methods]. Morphologie. 1999. 83:17–20.
19. Shih TT, Chang CJ, Hsu CY, Wei SY, Su KC, Chung HW. Correlation of bone marrow lipid water content with bone mineral density on the lumbar spine. Spine (Phila Pa 1976). 2004. 29:2844–2850.
Article
20. Rodríguez JP, Garat S, Gajardo H, Pino AM, Seitz G. Abnormal osteogenesis in osteoporotic patients is reflected by altered mesenchymal stem cells dynamics. J Cell Biochem. 1999. 75:414–423.
Article
21. Rodríguez JP, Montecinos L, Ríos S, Reyes P, Martínez J. Mesenchymal stem cells from osteoporotic patients produce a type I collagen-deficient extracellular matrix favoring adipogenic differentiation. J Cell Biochem. 2000. 79:557–565.
Article
22. Di Monaco M, Di Monaco R, Manca M, Cavanna A. Positive association between total lymphocyte count and femur bone mineral density in hip-fractured women. Gerontology. 2002. 48:157–161.
Article
23. Di Monaco M, Vallero F, Di Monaco R, Mautino F, Cavanna A. Total lymphocyte count and femoral bone mineral density in postmenopausal women. J Bone Miner Metab. 2004. 22:58–63.
Article
24. Laudisio A, Marzetti E, Pagano F, Bernabei R, Zuccalá G. Haemoglobin levels are associated with bone mineral density in the elderly: a population-based study. Clin Rheumatol. 2009. 28:145–151.
Article
25. Jassal SK, von Muhlen D, Barrett-Connor E. Measures of renal function, BMD, bone loss, and osteoporotic fracture in older adults: the Rancho Bernardo study. J Bone Miner Res. 2007. 22:203–210.
Article
26. Manolagas SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev. 2000. 21:115–137.
Article
27. Zhai G, Hart DJ, Valdes AM, Kato BS, Richards JB, Hakim A, et al. Natural history and risk factors for bone loss in postmenopausal Caucasian women: a 15-year follow-up population-based study. Osteoporos Int. 2008. 19:1211–1217.
Article
28. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001. 285:785–795.
29. Kim KC, Shin DH, Lee SY, Im JA, Lee DC. Relation between obesity and bone mineral density and vertebral fractures in Korean postmenopausal women. Yonsei Med J. 2010. 51:857–863.
Article
30. Chatta GS, Dale DC. Aging and haemopoiesis. Implications for treatment with haemopoietic growth factors. Drugs Aging. 1996. 9:37–47.
31. Shin CS, Choi HJ, Kim MJ, Kim JT, Yu SH, Koo BK, et al. Prevalence and risk factors of osteoporosis in Korea: a community-based cohort study with lumbar spine and hip bone mineral density. Bone. 2010. 47:378–387.
Article